Keyphrases
Urokinase-type Plasminogen Activator
100%
Soluble Urokinase Plasminogen Activator Receptor (suPAR)
80%
Urokinase
36%
Monoclonal Antibody
29%
Cell Surface Receptor
26%
U937 Cells
26%
Cell Surface
22%
Ligand-binding Domain
20%
Glycosylation
20%
Receptor Cleavage
17%
Receptor-interacting Protein Kinase 1 (RIPK1)
17%
Surface Velocity
17%
Human Endothelial Cells
17%
Amino Acid Sequence
17%
Ligand Binding
17%
Biosensor Technology
17%
Antibody-mediated
17%
Human Sarcoma
17%
Plasminogen Activator inhibitor-1 (PAI-1)
17%
Messenger RNA (mRNA)
17%
Human Receptor
17%
RNA-protein Complex
17%
Purified Proteins
17%
Plasminogen Activation System
17%
Potentiation
17%
Molecular Mass
16%
Immunology and Microbiology
Urokinase Receptor
65%
Cell Surface
49%
Amino Terminal Sequence
42%
Monoclonal Antibody
29%
Plasminogen Activation
29%
Plasmin
25%
Molecular Weight
21%
Glycosylation
20%
Amino Acid Sequence
17%
Ligand Binding
17%
Biochemistry, Genetics and Molecular Biology
Urokinase
82%
Urokinase Receptor
34%
Cell Surface Receptor
25%
Ligand Binding
23%
Enzyme
19%
Molecular Weight
17%
Plasminogen Activator Inhibitor-1
17%
Ligand Binding Domain
17%
Messenger RNA
17%
Monoclonal Antibody
16%
